Lexicon Pharmaceuticals | LXRX - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Abbott 30.71 14.41 2025-12
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Akebia Therapeutics 26.5 0.19 2023-09
Alnylam Pharmaceuticals 170.7 367.33 2025-12
AstraZeneca 27.29 5.8 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Eli Lilly 40.21 9.66 2025-12
Esperion Therapeutics 129.79 129 2024-12
Halozyme Therapeutics 23.16 7.7 2025-12
Illumina 30.38 15.53 2025-12
Ironwood Pharmaceuticals 204.24 88.19 2024-12
J&J 23.62 0.86 2025-12
Lexicon Pharmaceuticals 12.44 4.73 2021-06
MannKind 303.7 273.14 2025-12
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Novartis 15.74 0.15 2025-09
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Sarepta Therapeutics 27.27 0 2025-09
Thermo Fisher Scientific 31 6.22 2025-12
United Therapeutics 17.32 1.62 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06